| Zdroj: |
Maurer, M, Elberink, H O, Gotlib, J, Sabato, V, Hartmann, K, Broesby-Olsen, S, Castells, M, Deininger, M W, Heaney, M L, George, T I, Siebenhaar, F, Radia, D, Triggiani, M, van Daele, P, Deangelo, D J, Schmidt-Kittler, O, Lin, H-M, Morrison, A, Mar, B & Akin, C 2020, ' Results from PIONEER: A randomized, double-blind, placebo-controlled, phase 2 study of avapritinib in patients with indolent systemic mastocytosis (ISM) ', Oncology Research and Treatment, vol. 43, no. Suppl. 4, 384, pp. 77 . < https://doi.org/10.1159/000510995 > |
